We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Competition Commission of India (CCI) started a consultation process to gather views from pharma companies, doctors and other stakeholders as part of its ongoing study on the country’s pharma sector.
Anti-competition watch dog Competition Commission of India (CCI) has asked its Director General (DG) to conduct an investigation into the pricing pattern of super-specialty hospitals in and around Delhi.